2543673-19-2
2543673-19-2
Chemical Structure
DCC-3116
- CAS. Nr.: 2543673-19-2
- Formula:C26H36F3N7O2
- Molecular Weight:535.60
InChIKey: CNBTYICEJGEABG-UHFFFAOYSA-N
SMILES: O=C1N(CCCNC2=NC(NC3=CC=C(N4CCN(CC4)C)C=C3CC)=NC=C2C(F)(F)F)CCOCC1
Biological Activity: DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can inhibit autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects[1].
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
DCC-3116 | 99.84% | DCC-3116 is an orally active ULK1/2 inhibitor. DCC-3116 can inhibit autophagy in lung cancer cells by inhibiting KRASG12C signaling, thereby inhibiting the proliferation of lung cancer cells and exerting anti-cancer effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
Keywords
